IP Library Granted Patent US 7,358,229
Granted Patent B2
US 7,358,229 · App. 11/105,897 · Granted Apr 15, 2008

Deuterated cyclosporin analogs and their use as immunomodulating agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,358,229
App. No.
11/105,897
Granted
Apr 15, 2008
Kind
B2
Abstract

Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution of the cyclosporine A (CsA) molecule by: (1) Chemical substitution and optionally deuterium substitution of amino acid 1; and (2) deuterium substitution at key sites of metabolism of the cyclosporine A molecule such as amino acids 1, 4, 9. Also disclosed are methods of producing the cyclosporine derivatives and method of producing immunosuppression with reduced toxicity with the disclosed cyclosporine derivatives.

Claims (15)

1. A composition that comprises a mixture of compounds represented by structures A and B:

wherein R is selected from the group consisting of (i) —CH═CH—CH 3 , (ii) —CH═CH 2 , and (iii) —CD=CD 2 .

2. The composition of claim 1 wherein R is —CH═CH—CH 3 .

3. The composition of claim 1 wherein R is —CH═CH 2 .

4. The composition of claim 1 wherein R is —CD=CD 2 .

5. A pharmaceutical composition comprising a mixture of compounds represented by structures A and B and a pharmaceutically acceptable excipient:

wherein R is selected from the group consisting of (i) —CH═CH—CH 3 , (ii) —CH═CH 2 , and (iii) —CH═CD 2 .

6. The pharmaceutical composition of claim 5 wherein R is —CH═CH—CH 3 .

7. The pharmaceutical composition of claim 5 wherein R is —CH═CH 2 .

8. The pharmaceutical composition of claim 5 wherein R is —CD=CD 2 .

9. A method of producing immunosuppresssion comprising administering to an animal in need thereof, an effective amound of composition comprising a mixture of compounds represented by structures A and B:

wherein R is selected from the group consisting of (i) —CH═CH—CH 3 , (ii) —CH═CH 2 , and (iii) —CD=CD 2 .

10. The method of claim 9 wherein R is —CH═CH—CH 3 .

11. The method of claim 9 wherein R is —CH═CH 2 .

12. The method of claim 9 wherein R is —CD=CD 2 .

Assignments (4)
CHANGE OF NAME Recorded Apr 22, 2014
From: ISOTECHNIKA PHARMA INC.
To: AURINIA PHARMACEUTICALS INC.
Reel/Frame 032738/0353 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2011
From: PALADIN LABS INC.
To: ISOTECHNIKA PHARMA INC.
Reel/Frame 025976/0912 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2011
From: ISOTECHNIKA INC.
To: PALADIN LABS INC.
Reel/Frame 025969/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2006
From: NAICKER, SELVARAJ; YATSCOFF, RANDALL W.; FOSTER, ROBERT T.
To: ISOTECHNIKA INC.
Reel/Frame 017420/0039 →